Precision Biosciences logo

Precision Biosciences Share Price Today

(NASDAQ: DTIL)

Precision Biosciences share price is $5.23 & ₹445.55 as on 30 Apr 2025, 2.30 'hrs' IST

$5.23

▲

0.12

(2.35%)

Market is closed - opens 7 PM, 30 Apr 2025

View live Precision Biosciences share price in Dollar and Rupees. Guide to invest in Precision Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Precision Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Precision Biosciences share price movements

  • Today's Low: $5.06
    Today's High: $5.39

    Day's Volatility :6.17%

  • 52 Weeks Low: $3.61
    52 Weeks High: $13.44

    52 Weeks Volatility :73.13%

Precision Biosciences (DTIL) Returns

PeriodPrecision Biosciences IncS&P BSE Consumer DurablesNifty Smallcap 250
3 Months
5.5%
1.0%
0.2%
6 Months
-35.81%
-6.5%
-9.5%
1 Year
-50.24%
546.7%
-1.2%
3 Years
-91.86%
931.3%
64.7%

Precision Biosciences (DTIL) Key Statistics

in dollars & INR

Previous Close
$5.11
Open
$5.08
Today's High
$5.3925
Today's Low
$5.06
Market Capitalization
$58.0M
Today's Volume
$80.4K
52 Week High
$13.436
52 Week Low
$3.61
Revenue TTM
$68.7M
EBITDA
$-22.8M
Earnings Per Share (EPS)
$1.0
PE Ratio
5.11
Profit Margin
10.43%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
19.05%

How to invest in Precision Biosciences Stock (DTIL) from India?

It is very easy for Indian residents to invest directly in Precision Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Precision Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Precision Biosciences or DTIL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Precision Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Precision Biosciences shares which would translate to 0.163 fractional shares of Precision Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Precision Biosciences, in just a few clicks!

Returns in Precision Biosciences (DTIL) for Indian investors in Rupees

The Precision Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Precision Biosciences investment value today

Current value as on today

₹52,329

Returns

₹47,671

(-47.67%)

Returns from Precision Biosciences Stock

₹49,760 (-49.76%)

Dollar Returns

₹2,089 (+2.09%)

Indian investors sentiment towards Precision Biosciences (DTIL)

65%

Period: Mar 30, 2025 to Apr 29, 2025. Change in 30 Days versus previous period

Search interest for Precision Biosciences Stock from India on INDmoney has increased by 65% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Precision Biosciences

  • TANG CAPITAL MANAGEMENT LLC

    6.42%

  • Aquilo Capital Management, LLC

    5.12%

  • Goldman Sachs Group Inc

    2.88%

  • Vanguard Group Inc

    2.65%

  • Citadel Advisors Llc

    1.47%

  • Renaissance Technologies Corp

    1.05%

Analyst Recommendation on Precision Biosciences

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Precision Biosciences(by analysts ranked 0 to 5 stars)

Analyst Forecast on Precision Biosciences Stock (DTIL)

What analysts predicted

Upside of 462.14%

Target:

$29.40

Current:

$5.23

Insights on Precision Biosciences Stock (Ticker Symbol: DTIL)

  • Price Movement

    In the last 6 months, DTIL stock has moved down by -30.9%

  • Price Movement

    In the last 3 years, DTIL stock has moved down by -91.3%

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 576.0K → 638.0K (in $), with an average increase of 9.7% per quarter

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 168.35 Cr → 138.97 Cr (in ₹), with an average decrease of 17.5% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 25.99 Cr → -0.96 Cr (in ₹), with an average decrease of 103.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 32.74M → -17.74M (in $), with an average decrease of 79.1% per quarter

  • DTIL vs Avanti Feeds Ltd (1 yr)

    In the last 1 year, Avanti Feeds Ltd has given 68.7% return, outperforming this stock by 82.9%

  • DTIL vs Avanti Feeds Ltd (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 73.0% return, outperforming this stock by 120.4%

  • DTIL vs Kaveri Seed Company Ltd (3 yr)

    In the last 3 years, Kaveri Seed Company Ltd has given 168.3% return, outperforming this stock by 205.7%

  • DTIL vs Kaveri Seed Company Ltd (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 91.0% return, outperforming this stock by 182.3%

  • Price to Sales

    ForDTIL every $1 of sales, investors are willing to pay $0.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.6 for every $1 of sales.

Precision Biosciences Technicals Summary

Sell

Neutral

Buy

Precision Biosciences is currently in a neutral trading position according to technical analysis indicators.

Precision Biosciences (DTIL) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Precision Biosciences Inc logo
Precision Biosciences Inc
8.6%
-35.81%
-50.24%
-91.86%
-97.34%

About Precision Biosciences

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States. It offers ARCUS, a genome editing platform to DNA genome insertion, deletion, and repair. The company also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; PBGENE-PMM for the treatment of m.3243 associated primary mitochondrial myopathy (PMM) which is expected to submit an IND and/or CTA. In addition, it develops PBGENE-NVS for sickle cell disease/beta thalassemia for insertion; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. The company has license and collaboration agreement with Caribou Biosciences, Inc.; license agreement with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; Cellectis S.A.; iECURE, Inc. to develop ARCUS-based gene-insertion therapies; Duke University; and Novartis Pharma AG to discover and develop in vivo gene editing products. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
Organization
Precision Biosciences
Employees
108
CEO
Mr. Naresh Tanna
Industry
Biotechnology

Management People of Precision Biosciences

NameTitle
Mr. Michael Amoroso
President, CEO & Director
Dr. Jefferson J. Smith Ph.D.
Co-Founder & Chief Research Officer
Mr. John Alexander Kelly R.Ph.
CFO & Principal Accounting Officer
Dr. Cassie Gorsuch Ph.D.
Chief Scientific Officer
Mr. Naresh Tanna
Chief of Staff to CEO & Head of Investor Relations
Mr. Dario Scimeca J.D.
General Counsel & Secretary
Ms. Juli Blanche
Chief People Officer
Ms. Cindy Atwell
Chief Development & Business Officer
Mr. Neil Leatherbury M.S.
Senior VP and Head of Chemistry, Manufacturing & Controls
Dr. Murray Abramson M.D., M.P.H.
Senior VP & Head of Clinical Development

Important FAQs about investing in DTIL Stock from India :

What is Precision Biosciences share price today?

Precision Biosciences share price today stands at $5.23, Open: $5.08 ; Previous Close: $5.11 ; High: $5.39 ; Low: $5.06 ; 52 Week High: $13.44 ; 52 Week Low: $3.61.

The stock opens at $5.08, after a previous close of $5.11. The stock reached a daily high of $5.39 and a low of $5.06, with a 52-week high of $13.44 and a 52-week low of $3.61.

Can Indians buy Precision Biosciences shares?

Yes, Indians can invest in the Precision Biosciences (DTIL) from India.

With INDmoney, you can buy Precision Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Precision Biosciences at zero transaction cost.

How can I buy Precision Biosciences shares from India?

It is very easy to buy Precision Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Precision Biosciences (DTIL) be purchased?

Yes, you can buy fractional shares of Precision Biosciences with INDmoney app.

What are the documents required to start investing in Precision Biosciences stocks?

To start investing in Precision Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Precision Biosciences Stock (DTIL)?

Today’s highest price of Precision Biosciences (DTIL) is $5.39.

Today’s lowest price of Precision Biosciences (DTIL) is $5.06.

What is today's market capitalisation of Precision Biosciences?

Today's market capitalisation of Precision Biosciences DTIL is 58.0M

What is the 52 Week High and Low Range of Precision Biosciences Stock (DTIL)?

  • 52 Week High

    $13.44

  • 52 Week Low

    $3.61

What are the historical returns of Precision Biosciences (DTIL)?

  • 1 Month Returns

    8.6%

  • 3 Months Returns

    -35.81%

  • 1 Year Returns

    -50.24%

  • 5 Years Returns

    -97.34%

Who is the Chief Executive Officer (CEO) of Precision Biosciences ?

Mr. Naresh Tanna is the current Chief Executive Officer (CEO) of Precision Biosciences.